Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 29

1.

Salivary duct carcinoma: An aggressive salivary gland malignancy with opportunities for targeted therapy.

Schmitt NC, Kang H, Sharma A.

Oral Oncol. 2017 Nov;74:40-48. doi: 10.1016/j.oraloncology.2017.09.008. Epub 2017 Sep 21. Review.

PMID:
29103750
2.

Salivary duct carcinoma arising from the inferior turbinate.

Vallabh N, Srinivasan V, Hughes D, Agbamu D.

J Surg Case Rep. 2017 Jul 28;2017(7):rjx090. doi: 10.1093/jscr/rjx090. eCollection 2017 Jul.

3.

Impact of hematological inflammatory markers on clinical outcome in patients with salivary duct carcinoma: a multi-institutional study in Japan.

Kawakita D, Tada Y, Imanishi Y, Beppu S, Tsukahara K, Kano S, Ozawa H, Okami K, Sato Y, Shimizu A, Sato Y, Fushimi C, Takase S, Okada T, Sato H, Otsuka K, Watanabe Y, Sakai A, Ebisumoto K, Togashi T, Ueki Y, Ota H, Shimura T, Hanazawa T, Murakami S, Nagao T.

Oncotarget. 2017 Jan 3;8(1):1083-1091. doi: 10.18632/oncotarget.13565.

4.

Clinicopathological features and treatment outcomes of the rare, salivary duct carcinoma of parotid gland.

Al-Qahtani KH, Tunio MA, Bayoumi Y, Gurusamy VM, Bahamdain FA, Fatani H.

J Otolaryngol Head Neck Surg. 2016 May 16;45(1):32. doi: 10.1186/s40463-016-0146-2.

5.

Clinical Outcomes and Prognostic Factors for Salivary Duct Carcinoma: A Multi-Institutional Analysis of 141 Patients.

Otsuka K, Imanishi Y, Tada Y, Kawakita D, Kano S, Tsukahara K, Shimizu A, Ozawa H, Okami K, Sakai A, Sato Y, Ueki Y, Sato Y, Hanazawa T, Chazono H, Ogawa K, Nagao T.

Ann Surg Oncol. 2016 Jun;23(6):2038-45. doi: 10.1245/s10434-015-5082-2. Epub 2016 Jan 20.

6.

Breast carcinoma metastasis to the lacrimal gland: Two case reports.

Nickelsen MN, VON Holstein S, Hansen AB, Prause JU, Heegaard S.

Oncol Lett. 2015 Aug;10(2):1031-1035. Epub 2015 May 27.

7.

Ductal activation of oncogenic KRAS alone induces sarcomatoid phenotype.

Fu Y, Cruz-Monserrate Z, Helen Lin H, Chung Y, Ji B, Lin SM, Vonderfecht S, Logsdon CD, Li CF, Ann DK.

Sci Rep. 2015 Aug 20;5:13347. doi: 10.1038/srep13347.

8.

Salivary duct carcinoma: A clinopathological report of 11 cases.

Huang X, Hao J, Chen S, Deng R.

Oncol Lett. 2015 Jul;10(1):337-341. Epub 2015 May 6.

9.

HER2/neu negative salivary duct carcinoma of parotid: A case with forty months recurrence free follow up.

Gokavarapu S, Fonseca D, Puthamakula S, Reddy BP, Reddy BS, Murthy S.

Int J Surg Case Rep. 2015;8C:22-4. doi: 10.1016/j.ijscr.2015.01.011. Epub 2015 Jan 8.

10.

Salivary duct carcinoma of the parotid gland: A case report and review of the literature.

Xie S, Yang H, Bredell M, Shen S, Yang H, Jin L, Zhang S.

Oncol Lett. 2015 Jan;9(1):371-374. Epub 2014 Oct 31.

11.

Intraoral salivary duct carcinoma: A case report and a brief review.

Acharya S, Padmini S, Koneru A, Krishnapillai R.

J Oral Maxillofac Pathol. 2014 Sep;18(Suppl 1):S121-7. doi: 10.4103/0973-029X.141353.

12.

High-throughput profiling identifies clinically actionable mutations in salivary duct carcinoma.

Ku BM, Jung HA, Sun JM, Ko YH, Jeong HS, Son YI, Baek CH, Park K, Ahn MJ.

J Transl Med. 2014 Oct 25;12:299. doi: 10.1186/s12967-014-0299-6.

13.

Postoperative radiotherapy in salivary ductal carcinoma: a single institution experience.

Kim TH, Kim MS, Choi SH, Suh YG, Koh YW, Kim SH, Choi EC, Keum KC.

Radiat Oncol J. 2014 Sep;32(3):125-31. doi: 10.3857/roj.2014.32.3.125. Epub 2014 Sep 30.

14.

Oncogenic PIK3CA mutation and dysregulation in human salivary duct carcinoma.

Qiu W, Tong GX, Turk AT, Close LG, Caruana SM, Su GH.

Biomed Res Int. 2014;2014:810487. doi: 10.1155/2014/810487. Epub 2014 Jan 8.

15.

Complete Response to Trastuzumab-Based Chemotherapy in a Patient with Human Epidermal Growth Factor Receptor-2-Positive Metastatic Salivary Duct Carcinoma ex Pleomorphic Adenoma.

Kadowaki S, Yatabe Y, Hirakawa H, Komori A, Kondoh C, Hasegawa Y, Muro K.

Case Rep Oncol. 2013 Sep 10;6(3):450-5. doi: 10.1159/000355219. eCollection 2013.

16.

An immunohistochemical panel for reliable differentiation of salivary duct carcinoma and mucoepidermoid carcinoma.

Butler RT, Spector ME, Thomas D, McDaniel AS, McHugh JB.

Head Neck Pathol. 2014 Jun;8(2):133-40. doi: 10.1007/s12105-013-0493-5. Epub 2013 Sep 25.

17.
18.

Low-grade salivary duct carcinoma or low-grade intraductal carcinoma? Review of the literature.

Kuo YJ, Weinreb I, Perez-Ordonez B.

Head Neck Pathol. 2013 Jul;7 Suppl 1:S59-67. doi: 10.1007/s12105-013-0460-1. Epub 2013 Jul 3. Review.

19.

Salivary duct carcinoma: new developments--morphological variants including pure in situ high grade lesions; proposed molecular classification.

Simpson RH.

Head Neck Pathol. 2013 Jul;7 Suppl 1:S48-58. doi: 10.1007/s12105-013-0456-x. Epub 2013 Jul 3. Review.

20.

Survival rates and prognostic factors for infiltrating salivary duct carcinoma: Analysis of 228 cases from the Surveillance, Epidemiology, and End Results database.

Jayaprakash V, Merzianu M, Warren GW, Arshad H, Hicks WL Jr, Rigual NR, Sullivan MA, Seshadri M, Marshall JR, Cohan DM, Zhao Y, Singh AK.

Head Neck. 2014 May;36(5):694-701. doi: 10.1002/hed.23350. Epub 2013 Oct 7.

Supplemental Content

Support Center